Sung Lee insider trades

Open-market stock purchases and sales by Sung Lee, EVP, Chief Financial Officer at Cytokinetics Inc, from SEC Form 4 filings since Nov 25, 2019.

Recent trades

DateStockTradeValue
Jul 1, 2026CYTK Cytokinetics IncBought (not open market)$53.9K
Jul 1, 2026CYTK Cytokinetics IncSold$97.6K
Jul 1, 2026CYTK Cytokinetics IncBought (not open market)—
Jun 29, 2026CYTK Cytokinetics IncSold$266K
Jun 29, 2026CYTK Cytokinetics IncBought (not open market)—
Jun 29, 2026CYTK Cytokinetics IncBought (not open market)—
Jun 29, 2026CYTK Cytokinetics IncBought (not open market)—
Jun 29, 2026CYTK Cytokinetics IncBought (not open market)—
Jun 24, 2026CYTK Cytokinetics IncSold$3.2M
Jun 24, 2026CYTK Cytokinetics IncBought (not open market)—
Jun 24, 2026CYTK Cytokinetics IncBought (not open market)—
Jun 24, 2026CYTK Cytokinetics IncBought (not open market)—
Jun 24, 2026CYTK Cytokinetics IncBought (not open market)—
Jun 24, 2026CYTK Cytokinetics IncBought (not open market)—
Jun 24, 2026CYTK Cytokinetics IncBought (not open market)—
Jun 5, 2026TNGX Tango Therapeutics, IncBought (not open market)—
Jun 5, 2026TNGX Tango Therapeutics, IncBought (not open market)—
May 5, 2026CYTK Cytokinetics IncSold$1.8M
Apr 29, 2026TNGX Tango Therapeutics, IncBought (not open market)—
Apr 29, 2026TNGX Tango Therapeutics, IncBought (not open market)—
Mar 17, 2026CYTK Cytokinetics IncSold$307K
Mar 15, 2026CYTK Cytokinetics IncBought (not open market)—
Mar 15, 2026CYTK Cytokinetics IncBought (not open market)—
Mar 15, 2026CYTK Cytokinetics IncBought (not open market)—
Jan 2, 2026TNGX Tango Therapeutics, IncBought (not open market)—

Companies traded

  • CYTK Cytokinetics Inc: 5 sales, last Jul 1, 2026
  • TNGX Tango Therapeutics, Inc: other filings, last Jun 5, 2026
  • VIR Vir Biotechnology, Inc: 1 sale, last Mar 27, 2024
  • SGMO Sangamo Therapeutics, Inc: other filings, last Nov 25, 2020

Get free alerts when Sung Lee files a new trade →